Fate Therapeutics (FATE) Short Interest Ratio & Short Volume $1.27 +0.02 (+1.60%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Fate Therapeutics Short Interest DataFate Therapeutics (FATE) has a short interest of 11.20 million shares. This marks a -8.12% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.8, indicating that it would take 3.8 days of the average trading volume of 2.73 million shares to cover all short positions.Current Short Interest11,200,000 sharesPrevious Short Interest12,190,000 sharesChange Vs. Previous Month-8.12%Dollar Volume Sold Short$18.48 millionShort Interest Ratio3.8 Days to CoverLast Record DateDecember 31, 2024Outstanding Shares113,890,000 sharesPercentage of Shares Shorted9.83%Today's Trading Volume1,269,351 sharesAverage Trading Volume2,734,264 sharesToday's Volume Vs. Average46% Short Selling Fate Therapeutics? Sign up to receive the latest short interest report for Fate Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFATE Short Interest Over TimeFATE Days to Cover Over TimeFATE Percentage of Float Shorted Over Time Fate Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 12/31/202411,200,000 shares $18.48 million -8.1%N/A3.8 $1.65 12/15/202412,190,000 shares $22.31 million +7.4%N/A4.5 $1.83 11/30/202411,350,000 shares $35.98 million +9.2%N/A5 $3.17 11/15/202410,390,000 shares $20.99 million -34.7%N/A5.4 $2.02 10/31/202415,900,000 shares $37.68 million -1.0%N/A12.6 $2.37 10/15/202416,060,000 shares $48.98 million +13.3%N/A12.2 $3.05 9/30/202414,180,000 shares $49.63 million -5.7%N/A8.8 $3.50 9/15/202415,040,000 shares $60.46 million -0.9%N/A9.2 $4.02 8/31/202415,170,000 shares $55.67 million +8.9%N/A8.1 $3.67 8/15/202413,930,000 shares $47.22 million +0.9%N/A6.8 $3.39 Get the Latest News and Ratings for FATE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fate Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/31/202413,800,000 shares $73.55 million -32.0%N/A6.1 $5.33 7/15/202420,290,000 shares $78.93 million +2.1%N/A8.3 $3.89 6/30/202419,870,000 shares $65.17 million -6.1%N/A8.5 $3.28 6/15/202421,150,000 shares $76.35 million -5.3%N/A8.7 $3.61 5/31/202422,340,000 shares $82.21 million +7.4%N/A8.8 $3.68 5/15/202420,810,000 shares $88.23 million -6.0%N/A8 $4.24 4/30/202422,140,000 shares $87.45 million +17.0%N/A8.5 $3.95 4/15/202418,920,000 shares $106.71 million +14.7%N/A6.8 $5.64 3/31/202416,490,000 shares $121.04 million +25.3%19.0%5.8 $7.34 3/15/202413,160,000 shares $98.57 million -2.5%15.2%4.6 $7.49 2/29/202413,490,000 shares $95.64 million +1.4%15.6%5.1 $7.09 2/15/202413,310,000 shares $94.23 million +15.9%15.5%5.3 $7.08 1/31/202411,480,000 shares $70.72 million +6.6%12.4%4.7 $6.16 1/15/202410,770,000 shares $49.00 million +2.1%11.6%5.3 $4.55 12/31/202310,550,000 shares $39.46 million -2.1%11.4%5.8 $3.74 12/15/202310,780,000 shares $32.56 million -7.9%11.6%6.3 $3.02 11/30/202311,710,000 shares $29.16 million +0.9%12.6%5.6 $2.49 11/15/202311,610,000 shares $28.79 million -1.6%12.5%5.3 $2.48 10/31/202311,800,000 shares $21.36 million -14.5%12.7%5.2 $1.81 10/15/202313,800,000 shares $23.46 million -7.4%14.9%6.1 $1.70 9/30/202314,900,000 shares $31.59 million -38.7%16.1%6.6 $2.12 9/15/202324,290,000 shares $53.44 million -12.1%26.2%10.7 $2.20 8/31/202327,640,000 shares $69.38 million -2.3%29.8%12.7 $2.51 8/15/202328,290,000 shares $82.89 million +2.4%30.5%13.2 $2.93 7/31/202327,630,000 shares $114.11 million +7.6%29.9%12.9 $4.13 7/15/202325,670,000 shares $121.42 million -1.0%27.8%11.5 $4.73 6/30/202325,930,000 shares $123.43 million -11.9%28.1%10.6 $4.76 6/15/202329,440,000 shares $171.05 million +1.1%31.9%11.7 $5.81 5/31/202329,120,000 shares $147.06 million 0.0%31.5%11.2 $5.05 5/15/202329,130,000 shares $155.26 million +3.7%31.6%10.8 $5.33Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 4/30/202328,080,000 shares $170.45 million +4.3%30.7%10.3 $6.07 4/15/202326,920,000 shares $161.79 million -1.5%29.5%9.7 $6.01 3/31/202327,340,000 shares $155.84 million +26.7%30.0%9.1 $5.70 3/15/202321,580,000 shares $119.98 million +15.7%23.6%5.4 $5.56 2/28/202318,660,000 shares $114.20 million +10.7%20.4%5.1 $6.12 2/15/202316,850,000 shares $106.83 million +3.5%18.7%4.9 $6.34 1/31/202316,280,000 shares $97.03 million +5.4%17.8%4.9 $5.96 1/15/202315,450,000 shares $83.43 million -30.8%16.9%4.9 $5.40 12/30/202222,330,000 shares $225.31 million +10.3%24.5%7.8 $10.09 12/15/202220,240,000 shares $287.61 million -4.6%22.2%13.5 $14.21 11/30/202221,220,000 shares $441.80 million -4.1%23.2%16.6 $20.82 11/15/202222,120,000 shares $492.83 million -0.5%24.2%16.8 $22.28 10/31/202222,230,000 shares $465.05 million +2.1%24.4%16.3 $20.92 10/15/202221,780,000 shares $443.44 million +0.7%24.0%16.5 $20.36 9/30/202221,620,000 shares $484.50 million +3.9%23.8%16.5 $22.41 9/15/202220,800,000 shares $562.64 million +2.8%22.9%15 $27.05 8/31/202220,240,000 shares $529.07 million +1.6%22.3%13.6 $26.14 8/15/202219,920,000 shares $718.32 million -5.6%21.9%12.9 $36.06 7/31/202221,100,000 shares $644.18 million -0.6%23.3%13 $30.53 7/15/202221,220,000 shares $672.67 million -3.6%23.4%12.9 $31.70 6/30/202222,010,000 shares $545.41 million +6.8%24.4%13.6 $24.78 6/15/202220,600,000 shares $399.23 million +0.6%36.4%13.1 $19.38 5/31/202220,470,000 shares $472.86 million +14.4%22.6%14.3 $23.10 5/15/202217,900,000 shares $433.54 million +8.2%19.8%12.8 $24.22 4/30/202216,550,000 shares $472.67 million +3.4%18.3%12.9 $28.56 4/15/202216,000,000 shares $604.32 million +3.8%17.8%12.2 $37.77 3/31/202215,420,000 shares $597.83 million -1.7%17.1%11.3 $38.77 3/15/202215,690,000 shares $491.25 million +2.0%17.4%11.5 $31.31 2/28/202215,390,000 shares $531.72 million +11.9%17.1%10.8 $34.55 2/15/202213,760,000 shares $521.23 million +9.6%15.4%10 $37.88 1/31/202212,550,000 shares $520.95 million +7.5%14.0%9.8 $41.51 1/15/202211,670,000 shares $505.08 million +1.6%13.0%9.5 $43.28 12/31/202111,490,000 shares $672.28 million +6.3%12.8%10.2 $58.51 12/15/202110,810,000 shares $590.98 million -0.4%12.0%9.8 $54.67 11/30/202110,850,000 shares $596.86 million +7.0%12.1%11.7 $55.01 11/15/202110,140,000 shares $544.82 million -1.8%11.3%10.9 $53.73 10/29/202110,330,000 shares $555.75 million -3.9%11.6%9.7 $53.80 10/15/202110,750,000 shares $658.33 million -5.7%12.1%10.2 $61.24 9/30/202111,400,000 shares $675.68 million -3.4%12.8%11.4 $59.27 9/15/202111,800,000 shares $784.70 million -1.2%13.2%12 $66.50 8/31/202111,940,000 shares $874.61 million -3.1%13.4%11.6 $73.25 8/13/202112,320,000 shares $1.07 billion +0.8%13.8%12.2 $86.71 7/30/202112,220,000 shares $1.01 billion +5.0%13.7%13 $82.80 7/15/202111,640,000 shares $892.79 million -1.7%13.2%12 $76.70 6/30/202111,840,000 shares $1.03 billion +0.4%13.4%12.1 $86.79 6/15/202111,790,000 shares $1.02 billion -3.1%13.4%11.4 $86.79 5/28/202112,170,000 shares $932.22 million -6.5%13.8%12 $76.60 5/14/202113,020,000 shares $931.06 million +6.5%N/A12.9 $71.51 4/30/202112,230,000 shares $1.05 billion +1.3%N/A12.2 $85.87 4/15/202112,070,000 shares $1.02 billion +0.1%N/A12.3 $84.73Do this Before Elon’s Reveal on January 22nd (Ad)Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. 3/31/202112,060,000 shares $893.53 million +4.3%N/A11.6 $74.09 3/15/202111,560,000 shares $1.09 billion +12.2%N/A11.2 $93.99 2/26/202110,300,000 shares $888.58 million +7.0%N/A8.2 $86.27 2/12/20219,630,000 shares $987.08 million -4.5%N/A8 $102.50 1/29/202110,080,000 shares $916.37 million -0.8%N/A8.7 $90.91 1/15/202110,160,000 shares $1.19 billion -8.0%N/A8.9 $117.40 12/31/202011,040,000 shares $1.03 billion -15.6%N/A9.7 $93.62 12/15/202013,080,000 shares $1.26 billion -9.2%N/A12.2 $96.38 11/30/202014,400,000 shares $834.05 million +0.9%N/A13.2 $57.92 11/15/202014,270,000 shares $720.78 million -0.6%N/A16 $50.51 10/30/202014,350,000 shares $654.79 million -3.6%N/A16.7 $45.63 10/15/202014,880,000 shares $698.76 million +7.1%N/A17.4 $46.96 9/30/202013,900,000 shares $555.58 million +7.6%N/A17.2 $39.97 9/15/202012,920,000 shares $485.28 million +1.9%N/A16.2 $37.56 8/31/202012,680,000 shares $461.55 million +2.6%N/A16.2 $36.40 8/14/202012,360,000 shares $425.31 million +1.4%N/A13.6 $34.41 7/31/202012,190,000 shares $381.18 million -0.6%N/A12.1 $31.27 7/15/202012,260,000 shares $427.51 million -1.0%N/A12 $34.87 6/30/202012,380,000 shares $403.71 million +12.7%N/A11.6 $32.61 6/15/202010,990,000 shares $337.94 million -2.4%N/A9.5 $30.75 5/29/202011,260,000 shares $365.16 million -4.9%N/A9 $32.43 5/15/202011,840,000 shares $336.85 million +1.4%N/A9.7 $28.45 4/30/202011,680,000 shares $319.80 million +0.3%N/A10.4 $27.38 4/15/202011,640,000 shares $333.84 million +2.7%N/A10.4 $28.68 3/31/202011,330,000 shares $348.06 million +8.7%N/A9.6 $30.72 3/13/202010,422,300 shares $283.80 million +2.4%18.4%7.8 $27.23 2/28/202010,180,000 shares $226.81 million +5.1%18.0%9.6 $22.28 2/14/20209,690,000 shares $251.84 million +1.5%N/A9.7 $25.99 1/31/20209,550,000 shares $304.45 million -0.2%N/A9.7 $31.88 FATE Short Interest - Frequently Asked Questions What is Fate Therapeutics' current short interest? Short interest is the volume of Fate Therapeutics shares that have been sold short but have not yet been covered or closed out. As of December 31st, traders have sold 11,200,000 shares of FATE short. Learn More on Fate Therapeutics' current short interest. What is a good short interest ratio for Fate Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FATE shares currently have a short interest ratio of 4.0. Learn More on Fate Therapeutics's short interest ratio. Is Fate Therapeutics' short interest increasing or decreasing? Fate Therapeutics saw a drop in short interest in the month of December. As of December 31st, there was short interest totaling 11,200,000 shares, a drop of 8.1% from the previous total of 12,190,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Fate Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Fate Therapeutics: Erasca, Inc. (20.06%), ORIC Pharmaceuticals, Inc. (16.21%), Tectonic Therapeutic (7.34%), Kura Oncology, Inc. (16.00%), CARGO Therapeutics, Inc. (18.87%), Pharvaris (0.96%), Humacyte, Inc. (28.38%), Annexon, Inc. (8.42%), Keros Therapeutics, Inc. (10.64%), Mereo BioPharma Group plc (5.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.83 billion), Charter Communications, Inc. ($3.77 billion), Reddit, Inc. ($2.98 billion), The Kroger Co. ($2.97 billion), International Paper ($2.64 billion), SoFi Technologies, Inc. ($1.99 billion), Rivian Automotive, Inc. ($1.93 billion), Onsemi ($1.81 billion), SoundHound AI, Inc. ($1.59 billion), and Moderna, Inc. ($1.57 billion). View all of the most shorted stocks. What does it mean to sell short Fate Therapeutics stock? Short selling FATE is an investing strategy that aims to generate trading profit from Fate Therapeutics as its price is falling. FATE shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fate Therapeutics? A short squeeze for Fate Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FATE, which in turn drives the price of the stock up even further. How often is Fate Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FATE, twice per month. The most recent reporting period available is December, 31 2024. More Short Interest Resources from MarketBeat Related Companies ERAS Short Squeeze ORIC Short Squeeze TECX Short Squeeze KURA Short Squeeze CRGX Short Squeeze PHVS Short Squeeze HUMA Short Squeeze ANNX Short Squeeze KROS Short Squeeze MREO Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FATE) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementThe #1 Coin Poised to Soar Under Trump Pro-Crypto White House could make this the investment opportunity of...Crypto 101 Media | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fate Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fate Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FATE Stock Alerts